NCT03690414 - Evaluation of Short Term Use of Experimental Eye Drops BHVI2, 0.02% Atropine and BHVI2 Plus 0.02% Atropine Eye Drops | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 2, 2019

Study Completion Date

June 30, 2019

Conditions

Myopia

Interventions

DRUG

Experimental BHVI2

Experimental BHVI2 eye drops

DRUG

Atropine sulfate 0.02% eye drops

Atropine eye drops

COMBINATION_PRODUCT

Combination eye drops

Combination eye drops with experimental BHVI2 plus 0.02% atropine

Trial Locations (1)

Department of Ophthalmology - An Sinh Hospital, Ho Chi Minh City